Le Lézard
Classified in: Health
Subjects: CHI, SVY, DEI

Momentum Health receives FDA 510K Clearance for Momentum Spine, a Pioneering AI-Enabled Mobile Application for Monitoring Scoliosis, Available for Download Now!


After receiving their Health Canada class 1 medical device clearance, Momentum Spine continues to gain traction with FDA clearance and the launch of their mobile app. 

MONTREAL, Feb. 15, 2024 /CNW/ - Momentum Health Inc. is excited to announce that its innovative mobile application, Momentum Spine, has received U.S. Food and Drug Administration (FDA) clearance. This state-of-the-art AI application offers a non-invasive, radiation-free solution to quantify postural asymmetries, including scoliosis, directly targeting a long-standing challenge in managing spinal deformities.

DOWNLOAD NOW ON THE APP STORE (HERE) OR THE GOOGLE PLAY STORE (HERE)

Scoliosis is the most prevalent spine deformity affecting 3% of Children 1 and an estimated 68% of adults above 60 years old 2. It is defined as a sideways curvature of the spine in the coronal plane. The key to successful scoliosis management is early detection and frequent monitoring. However, in our current standard of care scoliosis patients are at elevated risks of cancer due to repetitive radiation exposure via X-Rays 3.

Momentum Spine is an AI-enabled digital health platform to remotely monitor postural asymmetries, including scoliosis, using a simple video taken on a smartphone. The platform can be used by clinicians and care teams to remotely monitor scoliosis patients with less radiation exposure and more continuous follow-up as well as the general population who would like to monitor their spine health.

LEARN MORE ABOUT MOMENTUM SPINE

With the recent FDA clearance, Momentum Health is progressing to the commercialization phase for the Momentum Spine technology. The company will offer their solution to health systems through institutional licenses and also make it available directly to consumers via app stores.

Key features and benefits of Momentum Spine include:

Dr. Jean Ouellet, a Pediatric Spine Surgeon and the Chief Medical Officer of Momentum Health Inc., shared his enthusiasm: "Receiving FDA clearance is a monumental achievement for Momentum Health. Momentum Spine not only empowers patients and healthcare providers with accurate and timely data but also signifies a leap in harnessing AI for spine care."

Try it for yourself TODAY!

**Indications for Use:**

The Momentum Spine app is an optical contour sensing mobile application intended to quantify asymmetries, assess body angles, and track curve progression related to postural asymmetries, including scoliosis. The application is available directly to lay users (Over-the-Counter) and may also be prescribed by physicians. It is designed for patients aged 8 years and older.

About Momentum Health Inc.:

Momentum Health Inc., based in Montreal, QC, is committed to creating groundbreaking digital health solutions that enhance patient care, optimize healthcare resources and empower individuals to quarterback their health.

References:

1- Mo, Fred, and Matthew E Cunningham. "Pediatric scoliosis." Current reviews in musculoskeletal medicine vol. 4,4 (2011): 175-82. doi:10.1007/s12178-011-9100-0


2- Konieczny, Markus Rafael et al. "Epidemiology of adolescent idiopathic scoliosis." Journal of children's orthopaedics vol. 7,1 (2013): 3-9. doi:10.1007/s11832-012-0457-4


3- Loughenbury, P. R., et al. "Estimated cumulative X-ray exposure and additional cancer risk during the evaluation and treatment of scoliosis in children and young people requiring surgery." Spine Deformity 9 (2021): 949-954. doi:10.1007/s43390-021-00314-6

 

SOURCE Momentum Health Inc.


These press releases may also interest you

at 07:15
The National Business League (NBL)®, National Medical Association (NMA)®, and National Bar Association (NBA)® are proud to announce a collaborative effort to address critical issues impacting Black communities. This initiative focuses on protecting...

at 07:05
Natera, Inc. , a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and...

at 06:58
"According to the latest BCC Research study, the demand for "Global Recombinant Proteins Market" is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through...

at 06:30
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Has Signed a ?37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium ? July 3, 2024, 12:30pm CET / 6:30am ET ? Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)...

at 06:30
Increasing pet ownership and the trend of treating pets as family members, the rising demand for livestock products due to a growing global population, and the need to manage zoonotic diseases to protect public health are some factors driving the...

at 06:00
The report "Anti-Migrating Agent Market by Type (Non-ionic, Anionic, Cationic, Amphoteric), Grades (Technical, Food, Pharmaceutical), Application, Chemistry (Organic, Inorganic), End-Use Industry (Textile, Plastics, Paper), and Region - Global...



News published on and distributed by: